Annals of Medicine
In the Ophthalmology section of Annals of Medicine we consider for publication the latest advances in:
General Ophthalmology •Glaucoma •International Ophthalmology •Neuro-ophthalmology
Ocular Oncology •Oculofacial Surgery •Oculoplastics •Pediatric Ophthalmology
Refractive Surgery •Uveitis
Two-Year Impact Factor 3.243
Five-Year Impact Factor 3.840
-Journal Citation Reports®
Meet the Section Editor
Professor Roman Shinder, MD FACS, Professor of Ophthalmology, Otolaryngology, Director of Oculoplastics, SUNY Downstate Medical Center, Brooklyn, NY
Professor Shinder, MD, FACS, was born in the Ukraine and grew up in New York City, NY, US. A graduate of Cornell University and SUNY Upstate Medical University, he then completed an Ophthalmology residency at the University of Medicine and Dentistry of New Jersey (now Rutgers). This was followed by a 2-year ophthalmic plastic and reconstructive surgery fellowship at MD Anderson Cancer Center. Since 2010, Dr. Shinder has been full-time faculty at SUNY Downstate Medical Center, and currently is Professor of Ophthalmology and Otolaryngology and also Director of Oculoplastics at SUNY Downstate and Kings County Hospital Center. He is Board Certified by the American Academy of Ophthalmology and is a member of the American Society of Ophthalmic Plastic and Reconstructive Surgeons. He is an invited charter member of the North American Society of Academic Orbital Surgeons, has published over 200 abstracts and peer-reviewed manuscripts, 13 textbook chapters and is Editor of a textbook currently in production. An Editorial Board member for the Asia-Pacific Journal of Ophthalmology and invited peer reviewer for several journals. Dr. Shinder has given a number of invited lectures throughout the world.
Why is Annals of Medicine the Best Publication for Your Research?
Fully open access, general medical journal publishing articles under a CC BY license, allowing maximum sharing and reuse of articles to our international readership;
Publishing all scientifically valid research, including reporting of negative and null data, from translational to clinical research in all disciplines and therapy areas;
Led by an international editorial team of subject experts who ensure a constructive and rigorous peer review process;
Your research is promoted via a tailored, multi-channel approach to maximize visibility, readership and impact.